期刊文献+

胆囊癌中吲哚胺2,3-双加氧酶的表达和调节性T细胞的浸润及其临床意义

Expression of indoleamine 2,3-dioxygenase and regulatory T cells infiltration in gallbladder carcinoma and clinical significance
原文传递
导出
摘要 目的探讨在胆囊癌(GC)中吲哚胺2,3-双加氧酶(IDO)表达和调节性T细胞(Tregs)的浸润及其与临床预后的关系。方法应用免疫组织化学技术EnVision法检测52例胆囊癌组织中IDO及Tregs的特异性标志物叉头状/翅翼状螺旋转录因子(FoxP3)的表达,15例慢性结石性胆囊炎组织进行对照,分析IDO、FoxP3的表达与临床病理特征及预后的关系。结果胆囊癌组织IDO强表达者(++~+++)19例(36.5%),缺失或弱表达者(-~+)33例(63.5%),Tregs的数量为(2.3±2.1)/HP,慢性胆囊炎标本中未见IDO及FoxP3表达;胆囊癌组织IDO与Tregs之间呈线性相关(r=0.619,P〈0.05);胆囊癌组织中IDO表达强度、Tregs数量与UICC分期、癌细胞分化程度相关(P〈0.05);肿瘤组织中IDO表达强度、Tregs数量、UICC分期是影响胆囊癌根治术后5年总生存率的独立危险因素(P〈0.05)。结论IDO的表达强度、局部浸润Tregs的数量与肿瘤的分级、分期相关;IDO的表达强度与Tregs的数量是影响胆囊癌根治术后5年总生存率的独立危险因素。 Objective To investigate the expression of indoleamine 2,3-dioxygenase (IDO) and regulatory T cells ( Tregs ) infiltration in gallbladder carcinoma ( GC ) and their correlation with clinical prognosis. Methods Immunohistochemistry was used to detect the expression of IDO and FoxP3 in the tissue samples of 52 GC cases, and 15 cases of chronic calculous cholecystitis as controls. The correlation between the expression of IDO and FoxP3 with clinicopathological features and prognosis was analyzed. Resuits Strong expression of IDO (++~+++ ) was detected in 19 GC cases ( 36. 5% ) and lack of or weak expression of IDO ( -~+ ) occurred in 33 GC cases (63.5%). IDO and FoxP3 staining was not seen in tissue samples of chronic calculous cholecystitis. The expression of IDO was significantly correlated with the number of Tregs in the tissue of GC (r =0. 619,P 〈0. 05) , and IDO and Tregs were significantly correlated with UICC stage and cancer cell differentiation ( P 〈 0. 05). Multivariate COX analysis revealed that IDO high expression, Tregs infiltration in tumor tissues and UICC stage emerged as independent prognosis variables for 5-year overall survival rate in GC patients. Conclusion The expression of IDO and Tregs infiltration in tissues of GC are related to tumor grade and stage. IDO expression and Tregs inflitration in tumors significantly contribute to disease progression and overall survival in patients whith GC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第7期1136-1138,I0002,共4页 Chinese Journal of Experimental Surgery
关键词 IDO TREGS FOXP3 胆囊癌 预后 Indoleamine 2,3-dioxygenase Regulatory T cells FoxP3 Gallbladder carcinoma Prognosis
  • 相关文献

参考文献16

  • 1Fong Y,Wagman L,Gonen M,et al.Evidengce-based gallbladder staging:cancer staging by analysis of data from the National Cancer Database.Ann Surg,2006,243:767-764.
  • 2Mapara MJ,Sykes M.Tolerance and cancer:mechanisms of tumor evasion and strategies for breaking tolerance.J Clin Oncol,2004,22:1136-1151.
  • 3Zou W.Immunosupressive netwoks in the tumoural enviroment and their therapeutic relevance.Nat Rev Cancer,2005,5:263-274.
  • 4Boon T,Van der Bruggen P.Human tumor antigens recognized by T lymphocytes.J Exp Med,1996,183:725-729.
  • 5Lennerz V,Fatho M,Gentilin C,et al.The response of autologous T cells to a human melanoma is dominated by mutated neoabtigens.Proc Natl Acad Sci USA,2005,102:16013-16018.
  • 6Van der Bruggen P,Van der Eynder BJ.Processing and presentation of tumor antigens and vaccination strategies.Curr Opin Immunol,2006,18:98-104.
  • 7Munn DH,Sharma MD,Hou D,et al.Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendric cells in tumor-draining lymph nodes.J Clin Invest,2004,114:280-290.
  • 8戴向晨,刘彤,瞿紫微,朱理玮,王鹏志.诱导小鼠树突细胞表达吲哚胺2,3双加氧酶的研究[J].中华实验外科杂志,2006,23(12):1539-1541. 被引量:5
  • 9Okamoto A,Nikaido T,Ochiai K,et al.Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene espression profiles of serous ovarian cancer cells.Clin Cancer Res,2005,11:6030-6039.
  • 10Gerald B,Alexander P.Prognosis value of indoleamine 2,3-dioxygenase expression in colorectal cancer.Clin Cancer Res,2006,12:1144-1151.

二级参考文献10

  • 1Zou WP. Regulatory T cells, Tumour immunity and immunotherapy. Nature Reviews Immunology,2006,6:295-306.
  • 2Beyer M, Schultze JL. Regulatory T cells in cancer. Blood,2006,108: 804-811.
  • 3Terness P, Bauer TM, Rose L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med, 2002, 196:447-457.
  • 4Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneie fetal rejection by tryptophan catabolism. Science, 1998,281 : 1191-1193.
  • 5FaUarino F, Vacca C, Orabona C, et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8α^+ dendritic cells. J Int Immunol,2002,14 : 65-68.
  • 6Grohmann U, Bianchi R, Belladonna ML, et al. IL-12 acts selectively on CD8α^+ dendritic cells to enhance presentation of a tumor peptide in vivo.J Immunol, 1999,163:3100-3105.
  • 7Grohmann U, Fallarino F, Bianchi R, et al. IL-6 Inhibits the tolerogenic function of CD8α^+ dendritic cells expressing Indoleamine 2,3-Dioxygenase. J Immunol,2001,167:708-714.
  • 8冯茂辉,熊斌,陈家宽,薛新波,吴洲清,杨国樑,王峰,胡名柏.丙氨酰-谷氨酰胺双肽对肿瘤术后患者热休克蛋白70及肿瘤坏死因子的影响[J].中华实验外科杂志,2007,24(12):1589-1590. 被引量:14
  • 9赵鸿,古涛,王翔,丁强,张元芳.白细胞介素-10诱导的大鼠树突状细胞体外免疫功能的研究[J].中华实验外科杂志,2003,20(5):450-452. 被引量:26
  • 10周景师,窦科峰,付蓉,孙凯,李海民.GM-CSF调节树突状细胞对移植免疫应答的影响[J].中华实验外科杂志,2004,21(2):189-191. 被引量:5

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部